Sign inJoin waitlistJoin the waitlist

Dipti Dighe

Chief, Section of Hematology/Oncology · University of Illinois Chicago

Credentials: · · ·

History

Section of Hematology/Oncology · University of Illinois Chicago
Present
University of Illinois Chicago
Present
University of Illinois Chicago
Present

Pediatric Hematology/Oncology
University of Illinois College of Medicine at Chicago
2003–2006
Hospital John H. Stroger, Jr. del Condado de Cook
2000–2003
Amaravati University
1997–2000
Universidad Amaravati, India
1993–1997
Pediatric Hematology/Oncology Fellow
University of Illinois College of Medicine at Chicago

Research

Retinoic acid fails to induce cell cycle arrest with myogenic differentiation in rhabdomyosarcoma
Pediatric Blood & Cancer · 2012 · 13 citations
A Tri-Institutional Approach to Address Disparities in Children's Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities
Journal of Adolescent and Young Adult Oncology · 2019 · 11 citations
Recurrent Severe Iron Deficiency Anemia and Thrombocytopenia in an Adolescent Male
Case report · Journal of Pediatric Hematology/Oncology · 2019 · Last of 5 authors · 6 citations

Lisa Giordano
5 papers
Asneha Iqbal
3 papers
Adrian Chapa-Rodriguez
1 paper · 1 as a resident
Alaa Altahan
1 paper
Alejandro Chea
1 paper · 1 as a fellow
AM
Alexandra Monde
1 paper · 1 as a fellow
DC
Daniel Choi
1 paper
Fouad Boulos
1 paper
IM
Ivy Mulinge
1 paper
Joanna Weinstein
1 paper
John Quigley
1 paper
Kathleen Breen
1 paper

Clinical trials

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2026–2031
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029